Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,715,299
-$68,477 QoQ
Shares Held
21,492
+7.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#744
of 2,284 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MCF Advisors LLC holds $26,128,918 across 16 Drug Manufacturers - General names. GILD ranks #6 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,362 | $6,441,187 | |
| 2 | AMGN |
Amgen Inc
|
12,335 | $4,466,750 | |
| 3 | LLY |
ELI LILLY & Co
|
3,535 | $4,239,985 | |
| 4 | ABBV |
AbbVie Inc.
|
12,627 | $3,177,458 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,882 | $3,068,837 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
21,492 | $2,715,299 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,023 | $980,865 | |
| 8 | PFE |
Pfizer Inc
|
27,882 | $671,398 |
All Filings in GILD
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,715,299 | 21,492 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,783,776 | 19,974 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,799,736 | 14,663 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $995,448 | 8,968 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $700,698 | 6,320 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $704,906 | 6,291 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $626,176 | 6,779 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $391,365 | 4,668 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $326,171 | 4,754 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $538,241 | 7,348 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $582,947 | 7,196 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $496,327 | 6,623 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $477,756 | 6,199 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $534,907 | 6,447 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $536,304 | 6,247 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $282,725 | 4,583 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $228,758 | 3,701 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $246,895 | 4,153 | Shares | Sole | 2022-05-05 | |
| 2021-09-30 | $208,921 | 2,991 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $127,115 | 1,846 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $19,841 | 307 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||